DAFNA Capital Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
137,593
-708,142
-84% -$7.62M 0.39% 46
2026
Q1
$7.15M Sell
845,735
-109,500
-11% -$1.2M 1.63% 17
2025
Q4
$10.8M Buy
955,235
+720,000
+306% +$8.92M 2.51% 10
2025
Q3
$3.53M Hold
235,235
0.87% 28
2025
Q2
$3.32M Buy
235,235
+15,000
+7% +$267K 0.92% 26
2025
Q1
$5.29M Hold
220,235
1.5% 19
2024
Q4
$8.23M Buy
220,235
+33,105
+18% +$1.54M 2.09% 15
2024
Q3
$9.35M Sell
187,130
-31,600
-14% -$1.23M 2.21% 15
2024
Q2
$7.59M Buy
218,730
+100,000
+84% +$3.95M 1.81% 21
2024
Q1
$6.49M Sell
118,730
-50,042
-30% -$2.48M 1.48% 22
2023
Q4
$7.22M Buy
168,772
+133,772
+382% +$4.16M 1.73% 17
2023
Q3
$910K Buy
35,000
+13,887
+66% +$289K 0.28% 60
2023
Q2
$505K Sell
21,113
-214,500
-91% -$3.69M 0.14% 61
2023
Q1
$3.22M Sell
235,613
-157,500
-40% -$2.51M 0.97% 32
2022
Q4
$5.46M Buy
393,113
+236,017
+150% +$3.33M 1.54% 20
2022
Q3
$967K Buy
+157,096
New +$1.14M 0.26% 57

Other funds holding BHVN

DAFNA Capital Management's BHVN Position: Q2 2026 in Review

DAFNA Capital Management reduced its Biohaven (BHVN) stake by 84% in Q2 2026, selling an estimated $7.62M and leaving 137,593 shares worth $2.05M. The position accounts for 0.39% of the portfolio, ranked #46.

DAFNA Capital Management first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $10.8M in Q4 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • DAFNA Capital Management held 137,593 shares of Biohaven worth $2.05M as of Q2 2026.
  • DAFNA Capital Management sold 708,142 Biohaven shares in Q2 2026, an estimated $7.62M.
  • Biohaven made up 0.39% of DAFNA Capital Management's portfolio in Q2 2026, its #46 holding.
  • DAFNA Capital Management first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
  • DAFNA Capital Management's Biohaven position peaked at $10.8M in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.